Literature DB >> 19032129

Calculation of AQCmax: comparison of five ophthalmic fluoroquinolone solutions*.

Masamichi Fukuda1, Hiroshi Sasaki.   

Abstract

UNLABELLED: ABSTRACT Objective: Ocular tissue penetration of five different ophthalmic fluoroquinolone solutions in the rabbit eye was measured and evaluated by an index of the maximum aqueous concentration (AQCmax).
METHODS: Moxifloxacin 0.5% (MFLX), levofloxacin 0.5% (LVFX), gatifloxacin 0.3% (GFLX), ofloxacin 0.3% (OFLX), or tosufloxacin tosilate 0.3% (TFLX) were instilled into the eyes of white rabbits every 15 min for a total of three doses. Aqueous humor, cornea, iris/ciliary body and vitreous body were collected 10 to 240 min after instillation and drug concentrations were measured by high-performance liquid chromatography.
RESULTS: The concentration of MFLX was the highest in each tissue, with maximum concentrations of MFLX in the aqueous humor (10.16 +/- 1.59 microg/mL) at 30 min after instillation, cornea (156.07 +/- 95.97 microg/g) and iris/ciliary body (11.92 +/- 4.00 microg/g) at 10 min after instillation, and vitreous body (0.099 +/- 0.033 microg/mL) at 30 min after instillation. The concentration of TFLX was the lowest in each tissue, with LVFX, GFLX, and OFLX sharing the mid-ranks. AQCmax : MIC(90) ratio for S. aureus was 150.67 for MFLX, 10.6 for LVFX, 9.69 for GFLX, 3.48 for OFLX, and could not be determined for TFLX.
CONCLUSION: AQCmax is a useful pharmacokinetic parameter for determining the therapeutic efficacy of an ophthalmic antibiotic, especially when combined with MIC(90) values for intraocular pathogens. C(max) of MFLX ophthalmic solution was superior in all tissues (cornea, aqueous humor, iris/ciliary body and vitreous body) among the five ophthalmic solutions studied, exceeding the MIC(90) of S. aureus in all tissues, and MIC(90)s of S. epidermidis, B. cereus, and P. acnes in aqueous humor, cornea, and iris/ciliary body. AQCmax was approximately proportional to C(max) in iris/ciliary body and vitreous, and may be used in combination with MIC(90)s as an index to predict the most appropriate dose and frequency of ophthalmic antibiotics in conjunction with other PK/PD parameters. This study may provide the groundwork for calculation of AQCmax in humans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19032129     DOI: 10.1185/03007990802480091

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  5 in total

Review 1.  Levofloxacin 0.5% ophthalmic solution: a review of its use in the treatment of external ocular infections and in intraocular surgery.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2009-06-18       Impact factor: 9.546

2.  Intraocular penetration of sequentially instilled topical moxifloxacin, gatifloxacin, and levofloxacin.

Authors:  Koji Sugioka; Masahiko Fukuda; Shohei Komoto; Motoki Itahashi; Masakazu Yamada; Yoshikazu Shimomura
Journal:  Clin Ophthalmol       Date:  2009-10-19

3.  Comprehensive evaluation of formulation factors for ocular penetration of fluoroquinolones in rabbits using cassette dosing technique.

Authors:  Charu Sharma; Nihar R Biswas; Shreesh Ojha; Thirumurthy Velpandian
Journal:  Drug Des Devel Ther       Date:  2016-02-22       Impact factor: 4.162

4.  Impact of Topically Administered Steroids, Antibiotics, and Sodium Hyaluronate on Bleb-Related Infection Onset: The Japan Glaucoma Society Survey of Bleb-Related Infection Report 4.

Authors:  Hideto Sagara; Tetsuya Yamamoto; Kimihiro Imaizumi; Tetsuju Sekiryu
Journal:  J Ophthalmol       Date:  2017-09-12       Impact factor: 1.909

5.  Pharmacokinetics of Azithromycin, Levofloxacin, and Ofloxacin in Rabbit Extraocular Tissues After Ophthalmic Administration.

Authors:  Tatsuya Sakai; Keisuke Shinno; Masaaki Kurata; Akio Kawamura
Journal:  Ophthalmol Ther       Date:  2019-08-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.